NIH-funded research R01 grant

Intelligent and Personalized Online Adaptive Proton Therapy

Funded at University of Chicago · NIH-11601037 · Data updated 2026-11-12

A new, AI-powered online system aims to tailor proton therapy in real time for patients with cancers near vital organs, to reduce side effects and improve outcomes.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startAugust 1, 2026
Project endApril 30, 2029
Funding year2026
Award (this year)$654,200
NIH project number7R01DE033512-03
Project IDNIH-11601037 on NIH RePORTER

Who could benefit from this research

Could help

Children and adults with cancers located near critical organs who receive proton therapy and are at risk from anatomical changes during treatment.

Less likely to help

Patients whose tumors do not require adaptive proton therapy or who cannot tolerate the treatment protocol.

What this research studies

This project uses smart imaging and AI to adapt proton therapy while a patient is on the treatment table, accounting for everyday changes in anatomy. It seeks to streamline the process so new treatment plans are available quickly, minimizing treatment interruptions. By focusing on pediatric and other sensitive anatomies, the goal is to keep the Bragg peak aligned with the tumor and spare healthy tissue. If successful, it could make adaptive proton therapy faster, more accurate, and more accessible in clinical practice.

Why it matters

Potential benefit: If successful, patients could receive more precise radiation with fewer side effects and shorter overall treatment times.

How similar studies have gone: Adaptive proton therapy approaches have shown promise in reducing dosing errors, but online, real-time methods are still being developed and validated.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Yang, Xiaofeng — University of Chicago
  • Study coordinator: Yang, Xiaofeng

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.